Showing results (341-350 of 465) with videos related to

Sort By:
Pageof 47
Journal of Applied Toxicology : JAT|April 16, 2016
Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) exampleS Dimitrov, A Detroyer, C Piroird, et al.
Plos One|October 27, 2010
Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague modelXiaodong Xiao, Zhongyu Zhu, Jennifer L Dankmeyer, et al.
Oncotarget|April 25, 2015
Assessment of folate receptor-β expression in human neoplastic tissuesJiayin Shen, Karson S Putt, Daniel W Visscher, et al.
Virology|April 24, 2018
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier categorySaikat Boliar, Shilpa Patil, Brihaspati N Shukla, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
Lancet (London, England)|December 6, 2001
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyM A Polis, I A Sidorov, C Yoder, et al.
Nucleic Acids Research|September 23, 2003
Evaluation of gene expression measurements from commercial microarray platformsPaul K Tan, Thomas J Downey, Edward L Spitznagel, et al.
Journal of Virology|September 19, 2008
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingKimberly A Bishop, Andrew C Hickey, Dimple Khetawat, et al.
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.
Mabs|March 11, 2016
Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1Weizao Chen, Ariola Bardhi, Yang Feng, et al.
Pageof 47